{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:24:56Z","timestamp":1772706296084,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"s4","license":[{"start":{"date-parts":[[2004,9,3]],"date-time":"2004-09-03T00:00:00Z","timestamp":1094169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>This review aims to provide an insight into some of the common pathways involved in the development of colorectal cancer \u2014 so\u2010called chromosomal instability and microsatellite instability. There is both clinical and molecular evidence to show that colorectal cancer development occurs over an extended period of time. Together with a knowledge of the molecular pathogenesis of colorectal cancer, this time window allows physicians to counteract cancer development, a strategy known as chemoprevention. In familial and sporadic colorectal cancer, aspirin, other nonsteroidal anti\u2010inflammatory drugs and cyclo\u2010oxygenase\u20102 inhibitors have been tested for their ability to reduce polyp and cancer development in clinical studies. In inflammatory bowel disease\u2010related colorectal cancer, evidence from retrospective case\u2013control studies shows that mesalazine (mesalamine) can reduce the development of dysplastic lesions or cancer. Although the mechanisms behind this are incompletely understood, general anti\u2010inflammatory, oxygen scavenger and some pro\u2010apoptotic and cyclo\u2010oxygenase inhibitory activities of mesalazine are thought to be involved. New molecular evidence points to a direct DNA stabilizing effect of mesalazine, resulting in a significant reduction of spontaneous microsatellite mutations.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02045.x","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T10:07:16Z","timestamp":1103450836000},"page":"31-35","source":"Crossref","is-referenced-by-count":12,"title":["The chemoprevention of colorectal carcinoma"],"prefix":"10.1111","volume":"20","author":[{"given":"C.","family":"Gasche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,3]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91163-X"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011013231802"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(01)02194-3"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/386623a0"},{"key":"e_1_2_7_6_2","first-page":"3075","article-title":"Mutator phenotype may be required for multistage carcinogenesis","volume":"51","author":"Loeb LA","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/363558a0"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2545"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.15.8698"},{"key":"e_1_2_7_10_2","first-page":"4841","article-title":"Microsatellite instability in ulcerative colitis\u2010associated colorectal dysplasias and cancers","volume":"54","author":"Suzuki H","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_7_11_2","first-page":"1237","article-title":"Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis","volume":"56","author":"Brentnall TA","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90280-5"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90293-9"},{"key":"e_1_2_7_14_2","first-page":"4864","article-title":"Microsatellite instability in inflammatory bowel disease\u2010associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1","volume":"60","author":"Fleisher AS","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_15_2","first-page":"7444","article-title":"Oxidative stress increases frameshift mutations in human colorectal cancer cells","volume":"61","author":"Gasche C","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00422.2001"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90161-9"},{"key":"e_1_2_7_18_2","first-page":"2035","article-title":"Adenomatous polyposis coli gene mutations in ulcerative colitis\u2010associated dysplasias and cancers versus sporadic colon neoplasms","volume":"55","author":"Tarmin L","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0502-e131"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni0302-221"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91068-S"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00698.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00484.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/24.3.443"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00652.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021633"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021735"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0437965100"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(08)80596-3"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02045.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02045.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02045.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:28:49Z","timestamp":1695814129000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02045.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,3]]},"references-count":28,"journal-issue":{"issue":"s4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02045.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02045.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,3]]}}}